Suppr超能文献

瑞芬太尼联合硫喷妥钠用于无肌肉松弛剂情况下的气管插管。

Remifentanil with thiopental for tracheal intubation without muscle relaxants.

作者信息

Durmus Mahmut, Ender Gedik, Kadir But A, Nurcin Gulhas, Erdogan Ozturk, Ersoy M Ozcan

机构信息

Department of Anesthesiology, Inonu University, School of Medicine, Malatya, Turkey.

出版信息

Anesth Analg. 2003 May;96(5):1336-1339. doi: 10.1213/01.ANE.0000061222.81081.71.

Abstract

UNLABELLED

Tracheal intubation may be accomplished with remifentanil and a non-opioid IV anesthetic without a muscle relaxant. In this study, we evaluated in double-blinded, prospective, randomized manner the dose requirements for remifentanil with thiopental without muscle relaxant administration to obtain clinically acceptable intubation conditions and cardiovascular responses. After premedication with midazolam 0.03 mg/kg IV, 105 patients were randomized equally to one of three study groups, each receiving the following: remifentanil 2 micro g/kg (Group I), 3 micro g/kg (Group II), and 4 micro g/kg (Group III). Remifentanil was administered over 30 s, and anesthesia was induced with thiopental 5 mg/kg. Tracheal intubation conditions were assessed by the anesthesiologist performing the intubation as: (a) excellent, (b) satisfactory, (c) fair, and (d) unsatisfactory. There were no statistically significant differences among groups regarding to demographic data. Blood pressure and heart rate did not increase in any group after accomplishing intubation. There was a significant improvement in intubation conditions between Groups I and II, I and III, and II and III (P < 0.001). We conclude that remifentanil 4 micro g/kg administered before thiopental 5 mg/kg provided excellent or satisfactory intubation conditions in 94% of patients and prevented cardiovascular responses to intubation.

IMPLICATIONS

We evaluated in a double-blinded manner the dose requirements for remifentanil with thiopental without muscle relaxants for obtaining acceptable intubation condition. Our results show that remifentanil 4 micro g/kg administered before thiopental provided excellent or satisfactory intubation condition in 94% of patients.

摘要

未标记

气管插管可在使用瑞芬太尼和非阿片类静脉麻醉药的情况下完成,无需使用肌肉松弛剂。在本研究中,我们采用双盲、前瞻性、随机的方式评估了在不使用肌肉松弛剂的情况下,瑞芬太尼与硫喷妥钠联合使用时达到临床可接受的插管条件和心血管反应所需的剂量。在静脉注射0.03mg/kg咪达唑仑进行术前用药后,105例患者被平均随机分为三个研究组,每组接受以下处理:瑞芬太尼2μg/kg(I组)、3μg/kg(II组)和4μg/kg(III组)。瑞芬太尼在30秒内给药,然后用5mg/kg硫喷妥钠诱导麻醉。由进行插管的麻醉医生评估气管插管条件为:(a)优,(b)良,(c)中,(d)差。各组间人口统计学数据无统计学显著差异。插管完成后,任何一组的血压和心率均未升高。I组与II组、I组与III组以及II组与III组之间的插管条件有显著改善(P < 0.001)。我们得出结论,在5mg/kg硫喷妥钠之前给予4μg/kg瑞芬太尼,94%的患者可获得优或良的插管条件,并可预防插管时的心血管反应。

启示

我们采用双盲方式评估了瑞芬太尼与硫喷妥钠联合使用且不使用肌肉松弛剂时达到可接受插管条件所需的剂量。我们的结果表明,在硫喷妥钠之前给予4μg/kg瑞芬太尼,94%的患者可获得优或良的插管条件。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验